Opes Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,766
Closed -$243K 65
2017
Q1
$243K Buy
+2,766
New +$243K 0.17% 49